Cargando…

Biomarkers in the diagnosis of pleural diseases: a 2018 update

The use of biomarkers on pleural fluid (PF) specimens may assist the decision-making process and enhance clinical diagnostic pathways. Three paradigmatic examples are heart failure, tuberculosis and, particularly, malignancy. An elevated PF concentration of the amino-terminal fragment of probrain na...

Descripción completa

Detalles Bibliográficos
Autor principal:	Porcel, José M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204620/ https://www.ncbi.nlm.nih.gov/pubmed/30354850 http://dx.doi.org/10.1177/1753466618808660

Ejemplares similares

Diagnosis exjuvantibus of a persistent pleural effusion
por: Porcel, José M.
Publicado: (2013)

Malignant Pleural Effusions: Updates in Diagnosis and Management
por: Hughes, Stephen M., et al.
Publicado: (2022)

Chest Tube Drainage of the Pleural Space: A Concise Review for Pulmonologists
por: Porcel, José M.
Publicado: (2018)

Diving into the Pleural Fluid: Liquid Biopsy for Metastatic Malignant Pleural Effusions
por: Sorolla, Maria Alba, et al.
Publicado: (2021)

Pleural diseases and COVID-19: ubi fumus, ibi ignis
por: Porcel, José M.
Publicado: (2020)

Update on pleural diseases - 2007
por: Bishay, Ayman, et al.
Publicado: (2007)

Recent Insights into the Management of Pleural Infection
por: Hassan, Maged, et al.
Publicado: (2021)

Identifying Thoracic Malignancies Through Pleural Fluid Biomarkers: A Predictive Multivariate Model
por: Porcel, José M., et al.
Publicado: (2016)

Malignant pleural mesothelioma: an update
por: Hajj, Glaucia N. M., et al.
Publicado: (2021)

Prevalence, clinical characteristics, and outcome of pleural effusions in ovarian cancer
por: Porcel, José M., et al.
Publicado: (2021)

Pleural Mesothelioma: Advances in Blood and Pleural Biomarkers
por: Sorino, Claudio, et al.
Publicado: (2023)

Pleural Infection Caused by Nocardia farcinica: Two Cases and Review of the Literature
por: Bagüeste, Graciella, et al.
Publicado: (2021)

Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment
por: Bibby, Anna C., et al.
Publicado: (2016)

Diagnosis of infectious pleural effusion using predictive models based on pleural fluid biomarkers
por: Ferreiro, Lucía, et al.
Publicado: (2019)

Secreted and Tissue miRNAs as Diagnosis Biomarkers of Malignant Pleural Mesothelioma
por: Martínez-Rivera, Vanessa, et al.
Publicado: (2018)

Malignant pleural effusion: Updates in diagnosis, management and current challenges
por: Addala, Dinesh Narayan, et al.
Publicado: (2022)

An Update in the Management of Malignant Pleural Effusion
por: Muduly, DK, et al.
Publicado: (2011)

New Updates of the Imaging Role in Diagnosis, Staging, and Response Treatment of Malignant Pleural Mesothelioma
por: Romei, Chiara, et al.
Publicado: (2021)

Calprotectin: a novel biomarker for the diagnosis of pleural effusion
por: Sánchez-Otero, N, et al.
Publicado: (2012)

Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma: 2018 update
por: Kim, Tae-Hyung, et al.
Publicado: (2019)

Channelopathies – An update 2018
por: Natarajan, K.U., et al.
Publicado: (2019)

Malignant pleural effusion: from bench to bedside
por: Psallidas, Ioannis, et al.
Publicado: (2016)

Pleural Fluid GSDMD Is a Novel Biomarker for the Early Differential Diagnosis of Pleural Effusion
por: Li, Pu, et al.
Publicado: (2021)

A novel biomarker for pleural effusion diagnosis: Interleukin‐36γ in pleural fluid
por: Guo, Lun, et al.
Publicado: (2022)

Update in Infectious Diseases 2018
por: Candel, Francisco Javier, et al.
Publicado: (2019)

Pleural biomarkers in diagnostics of malignant pleural effusion: a narrative review
por: Zhang, Man, et al.
Publicado: (2021)

Update on Novel Targeted Therapy for Pleural Organization and Fibrosis
por: Tucker, Torry A., et al.
Publicado: (2022)

An Update on Emerging Therapeutic Options for Malignant Pleural Mesothelioma
por: Davis, Alexander, et al.
Publicado: (2022)

Pleural Fluid Soluble Interleukin-2 Receptor as a Biomarker for the Diagnosis of Tuberculosis Pleural Effusion: A Systematic Review and Meta-Analysis
por: Yan, Zhi, et al.
Publicado: (2022)

Malignant Pleural Effusion: Diagnosis and Management
por: Ferreiro, Lucía, et al.
Publicado: (2020)

Pleural effusion: diagnosis, treatment, and management
por: Karkhanis, Vinaya S, et al.
Publicado: (2012)

Update on Sjögren’s Syndrome 2018
por: Argyropoulou, Ourania D., et al.
Publicado: (2018)

Circulating biomarkers in malignant pleural mesothelioma
por: Viscardi, Giuseppe, et al.
Publicado: (2020)

Essential updates 2018/2019: Colorectal (benign): Recent updates (2018‐2019) in the surgical treatment of benign colorectal diseases
por: Ogino, Takayuki, et al.
Publicado: (2019)

Biomarkers in Glycogen Storage Diseases: An Update
por: Molares-Vila, Alberto, et al.
Publicado: (2021)

Nicotinamide phosphoribosyltransferase as a biomarker for the diagnosis of infectious pleural effusions
por: Huang, Jing, et al.
Publicado: (2021)

Practical Significance of Biomarkers in Axial Spondyloarthritis: Updates on Diagnosis, Disease Activity, and Prognosis
por: Diaconu, Alexandra-Diana, et al.
Publicado: (2022)

Update on biomarkers in systemic sclerosis: tools for diagnosis and treatment
por: Affandi, Alsya J., et al.
Publicado: (2015)

Update on Epidemiology, Diagnosis, and Biomarkers in Gastroenteropancreatic Neuroendocrine Neoplasms
por: Takayanagi, Daisuke, et al.
Publicado: (2022)

EV-associated miRNAs from pleural lavage as potential diagnostic biomarkers in lung cancer
por: Roman-Canal, Berta, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_q9thds8pk2k3ukgvl1kdrqvj8f